Press 06.22.2026 Cognito Therapeutics to Present New Data Highlighting Effects of Spectris™ on Lipid Transport Biomarkers in Alzheimer’s Disease at AAIC 2026 Business Wire Share Article
Cognito Shares HOPE Study Results at CTAD Business Wire 11.16.2026 Read More: Cognito Shares HOPE Study Results at CTAD
Cognito Expands Executive Leadership Team Business Wire 11.12.2026 Read More: Cognito Expands Executive Leadership Team
Rhode Island Life Science Hub and Cognito Therapeutics Launch Brain Health Collaboratory to Advance Innovation in Alzheimer’s Disease PR Newswire 10.13.2026 Read More: Rhode Island Life Science Hub and Cognito Therapeutics Launch Brain Health Collaboratory to Advance Innovation in Alzheimer’s Disease